Login to Your Account

SCOTUS: Drug Safety Is a Federal, Not State, Issue

By Mari Serebrov
Washington Editor

Monday, June 24, 2013
When it comes to generic drugs, and possibly biosimilars in the future, federal law is the law of the land, the Supreme Court reiterated Monday, overturning a $21 million jury award based on state design-defect claims.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription